Illumina CEO Jay T. Flatley on producing new human genome technology.
Mikhail Shapiro of Third Rock Ventures on the GET Conference and which companies he is looking to invest in.
NYU Professor Dr. Mark Siegel on a series of treatments that could be squeezed out with health reform.
Leerink Swann Director of Equity Research John Sullivan on pharmaceutical companies tailoring drugs to people's specific genetic makeup.
OrbiMed Advisors' Dr. Robert Glassman on controversy over new mammogram guidelines.
The Health Care myth
Genoptix CEO on the booming biotech industry
Professor George Church on creating personal genome sequences for individuals and how this will affect our health in the future.
Isilon Systems Director of Marketing Chris Blessington on innovations in data storage and how it’s helping genome sequencing.
Under30CEO Co-Founder Jared O'Toole discusses how he helps start-ups flourish.
Fox News Medical Contributor Dr. Marc Siegel weighs in on the current trend in DNA testing.
Jorge Conde, CEO of Knome, explains the cost and value of consumer genetic sequencing.
Greg Lucier, CEO of Life Technologies talks about the potential uses for genetic sequencing, from cancer treatments to finding the right biofuel.
Illumina CEO Jay Flatley on how advances in technology have led mapping time to decrease from years to weeks.